Funds holding QUINCE THERAPEUTICS INC
ISIN US22053A1079 · United States
- Fund holders
- 0
No tracked fund declares this company in its latest report.
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 8 | -7 | 1,013,978 | -57.0 % |
| 2026Q1 | 15 | +3 | 2,360,244 | +24.0 % |
| 2025Q4 | 12 | 0 | 1,903,425 | -3.6 % |
| 2025Q3 | 12 | 0 | 1,974,735 | +9.6 % |
| 2025Q2 | 12 | +1 | 1,802,260 | +2.2 % |
| 2025Q1 | 11 | -3 | 1,763,946 | +7.2 % |
| 2024Q4 | 14 | -2 | 1,644,987 | -3.7 % |
| 2024Q3 | 16 | -1 | 1,708,131 | +5.9 % |
| 2024Q2 | 17 | -1 | 1,612,241 | +14.1 % |
| 2024Q1 | 18 | -2 | 1,413,350 | +3.6 % |
| 2023Q4 | 20 | 1,363,947 |
Institutional managers
35 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Woodline Partners LP | 5,200,000 | 527.3K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,503,717 | 253.9K $ | as of Mar 31, 2026 |
| Shay Capital LLC | 1,772,909 | 179.8K $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,750,862 | 176 $ | as of Mar 31, 2026 |
| IEQ CAPITAL, LLC | 600,105 | 60.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 473,259 | 48K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 248,011 | 25.1K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 172,640 | 17.5K $ | as of Mar 31, 2026 |
| SIMPLEX TRADING, LLC | 154,093 | 15.6K $ | as of Mar 31, 2026 |
| Vanguard Personalized Indexing Management, LLC | 132,661 | 13.5K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 71,223 | 7.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 65,930 | 6.7K $ | as of Mar 31, 2026 |
| Intellectus Partners, LLC | 53,312 | 5.4K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 50,100 | 5.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 48,812 | 5K $ | as of Mar 31, 2026 |
| Nordwand Advisors, LLC | 20,000 | 2K $ | as of Mar 31, 2026 |
| Scharf Investments, LLC | 19,461 | 2K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 16,064 | 1.6K $ | as of Mar 31, 2026 |
| Cambridge Investment Research Advisors, Inc. | 15,200 | 2 $ | as of Mar 31, 2026 |
| Belvedere Trading LLC | 13,080 | 1.3K $ | as of Mar 31, 2026 |
| Alpha Zero LLC | 13,000 | 1.3K $ | as of Mar 31, 2026 |
| Mariner, LLC | 12,673 | 1.3K $ | as of Mar 31, 2026 |
| NIXON PEABODY TRUST CO | 11,126 | 1.1K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 10,933 | 1.1K $ | as of Mar 31, 2026 |
| Coyle Financial Counsel LLC | 10,509 | 1.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding QUINCE THERAPEUTICS INC". https://titelia.com/en/stocks/quince-therapeutics-inc-US22053A1079